We explored (1) differences in adiponectin, leptin and resistin levels in MS and how these relate to clinical, disability, and MRI measures, adjusted and unadjusted for BMI and (2) how BMI relates to clinical, disability and MRI measures. The gene discussed is LEP; the disease is myeloid sarcoma.